Increase in prescription opioid use during pregnancy among Medicaid-enrolled women
- PMID: 24785852
- PMCID: PMC4020039
- DOI: 10.1097/AOG.0000000000000208
Increase in prescription opioid use during pregnancy among Medicaid-enrolled women
Abstract
Objective: To report the prevalence of prescription opioid use and evaluate the trends in a large cohort of Medicaid-enrolled pregnant women.
Methods: A cohort of pregnancies was identified using data from the Medicaid Analytical eXtract for the period of 2000-2007. Dispensing of opioids, as a class and separately for individual agents, was evaluated using claims from filled prescriptions. Variations in patterns of prescription opioid fills were examined by demographic characteristics, by geographic region, and over time. Median number of opioid prescriptions dispensed and cumulative days of availability for prescription opioids during pregnancy were reported.
Results: The study population consisted of more than 1.1 million women with completed pregnancies from 46 U.S. states and Washington, DC. One of five women from our cohort (21.6%) filled a prescription for an opioid during pregnancy; this proportion increased from 18.5% in 2000 to 22.8% in 2007. Substantial regional variation was seen with the proportion of women who filled a prescription during pregnancy, ranging between 9.5% and 41.6% across the states. Codeine and hydrocodone were the most commonly prescribed opioids. Among women filling at least one opioid prescription, the median (interquartile range) number of prescriptions filled was 1 (1-2) and the median (interquartile range) cumulative days of opioid availability during pregnancy were 5 (3-13) days.
Conclusion: We observed high and increasing number of filled prescriptions for opioids during pregnancy among Medicaid-enrolled women. These findings call for further safety evaluations of these drugs and their effects on the developing fetus to inform clinical practice.
Level of evidence: II.
Figures
Comment in
-
Increase in prescription opioid use during pregnancy among medicaid-enrolled women.Obstet Gynecol. 2014 Sep;124(3):637-638. doi: 10.1097/AOG.0000000000000446. Obstet Gynecol. 2014. PMID: 25162277 No abstract available.
-
In Reply: Cho et al.Obstet Gynecol. 2014 Sep;124(3):638. doi: 10.1097/AOG.0000000000000445. Obstet Gynecol. 2014. PMID: 25162278 No abstract available.
Similar articles
-
Prescription Opioid Use among Pregnant Women Enrolled in Rhode Island Medicaid.R I Med J (2013). 2019 Aug 1;102(6):35-40. R I Med J (2013). 2019. PMID: 31398967 Free PMC article.
-
Chronic prescription opioid use in pregnancy in the United States.Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):504-513. doi: 10.1002/pds.5194. Epub 2021 Jan 17. Pharmacoepidemiol Drug Saf. 2021. PMID: 33428239
-
Filled Prescriptions for Opioids After Vaginal Delivery.Obstet Gynecol. 2017 Mar;129(3):431-437. doi: 10.1097/AOG.0000000000001868. Obstet Gynecol. 2017. PMID: 28178050 Free PMC article.
-
Opioid prescription claims among women of reproductive age--United States, 2008-2012.MMWR Morb Mortal Wkly Rep. 2015 Jan 23;64(2):37-41. MMWR Morb Mortal Wkly Rep. 2015. PMID: 25611168 Free PMC article.
-
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.JAMA Netw Open. 2022 Aug 1;5(8):e2228588. doi: 10.1001/jamanetworkopen.2022.28588. JAMA Netw Open. 2022. PMID: 36001312 Free PMC article.
Cited by
-
Exploring low back and pelvic pain challenges: Administrative insights into prevalence during pregnancy among 2016-2021 South Carolina Medicaid beneficiaries.Womens Health (Lond). 2024 Jan-Dec;20:17455057241267097. doi: 10.1177/17455057241267097. Womens Health (Lond). 2024. PMID: 39282748 Free PMC article.
-
Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology.Front Cell Neurosci. 2024 May 15;18:1403326. doi: 10.3389/fncel.2024.1403326. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38812788 Free PMC article. Review.
-
Prevalence of Opioid Use in Nursing Homes Over the Last Decade: A Systematic Literature Review.J Pharm Technol. 2024 Jun;40(3):123-133. doi: 10.1177/87551225231217903. Epub 2023 Dec 23. J Pharm Technol. 2024. PMID: 38784025
-
A population-based descriptive study of neonatal abstinence syndrome using hospital discharge and birth certificate data.J Subst Use. 2023;28(5):789-796. doi: 10.1080/14659891.2022.2098841. Epub 2022 Jul 14. J Subst Use. 2023. PMID: 38751610 Free PMC article.
-
Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010-2019.Sci Adv. 2024 May 10;10(19):eadg9674. doi: 10.1126/sciadv.adg9674. Epub 2024 May 8. Sci Adv. 2024. PMID: 38718116 Free PMC article.
References
-
- Broussard CS, Rasmussen SA, Reefhuis J, Friedman J, Jann MW, Riehle-Colarusso T, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314, e311–311. - PubMed
-
- Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934–1940. - PubMed
-
- Garcia G. Maternal and Child Health (MCH) Update: States Increase Eligibility for Children’s Health in 2007. National Governors Association; 2008.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
